News
IICT transfers Favipiravir production process to Cipla; develops low cost Covid-19 test kit
Indian Institute of Chemical Technology has developed a cost-effective synthetic process for producing antiviral drug Favipiravir and has also developed an affordable RT-PCR kit.
Glenmark receives DCGI approval to conduct trials in India on Favipiravir antiviral tablets for COVID-19 patients
The product is a generic version of Avigan of Fujifilm Toyama. Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.
IIT M-incubated startup develops nanoparticle coating material to ‘inactivate’ Coronavirus on contact
Using Muse wearables’ coating machine, nanoparticles-based Antimicrobial agents can be coated on textiles, which can be used for N95, surgical masks, PPE equipment and food packaging bags
